Remifentanil and Glycemic Response in Cardiac Surgery

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study evaluates the effect of using remifentanil during cardiopulmonary bypass surgery to supress the hyperglycemic response in perioperative period. Half of the participants will receive continuous intravenous remifentanil during surgery, while the other half will receive intermittent intravenous fentanyl during surgery. Intermittent intravenous fentanyl administration is this institution\'s standard of care.
Epistemonikos ID: 02bc07cd4c7d93a020a8b8b4540e0dbc5da09243
First added on: May 12, 2024